Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[High macrolides and fluoroquinolones resistance rate in Mycoplasma genitalium in southern Tenerife].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 1 Aug 2023

Mateo León C, García Martínez de Artola D, Pino-Calm B

Abstract excerpt

OBJECTIVE: Mycoplasma genitalium (MG) is a recognized sexually transmitted pathogen. Increasing resistance to main lines of treatment (macrolides and quinolones) justifies a genetic study of mutations to improve cure rates. METHODS: A total of 8,508 samples from April 2018 to July 2022 were processed using AllplexTM STI Essential Assay. In MG positive cases 23S rRNA V domain, gyrA and parC genes were studied....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluoroquinolones

Share to Macrolides

Share to Mycoplasma genitalium

Share to Mycoplasma Infections

Share to Prevalence

Share to RNA, Ribosomal, 23S

Source

Open in PubMed Open full text

Identifiers

PMID: 37149902
DOI: 10.37201/req/014.2023
PMCID: PMC10336312

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[High macrolides and fluoroquinolones resistance rate in Mycoplasma genitalium in southern Tenerife].PMID 37149902Read ↗

Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy.Semantic proximity Read ↗

[Determination of Gene Mutations Associated with Macrolide and Fluoroquinolone Resistance in Patients Infected with Mycoplasma genitalium].Semantic proximity Read ↗

Macrolide and fluoroquinolone resistance associated mutations in Mycoplasma genitalium in men who have sex with men attending STI clinic: A pilot study from India.Semantic proximity Read ↗

Estimation of antimicrobial resistance of Mycoplasma genitalium, Belgium, 2022.Semantic proximity Read ↗

Antibiotic Resistance and Genotypes of Mycoplasma genitalium during a Resistance-Guided Treatment Regime in a German University HospitalSemantic proximity Read ↗

Epidemiology and prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium in a tertiary hospital from Madrid, Spain.Semantic proximity Read ↗

Trends of Mycoplasma genitalium infections in Berlin, Germany, 2017-2023.Semantic proximity Read ↗

Macrolide and fluoroquinolone resistance of Mycoplasma genitalium in southern Spain, 2018-2019.Semantic proximity Read ↗

Mycoplasma genitalium infection and resistance-associated mutations to macrolides and fluoroquinolones among high-risk patients in Taiwan.Semantic proximity Read ↗

Prevalence and macrolide resistance of Mycoplasma genitalium from patients seeking sexual health care in Southern Ghana.Semantic proximity Read ↗

Azithromycin and moxifloxacin resistance determinants in Mycoplasma genitalium in Lleida, Spain.Semantic proximity Read ↗

An alarming high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: results from samples collected between 2015 and 2018.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.